Home » TSI Group Ltd is first to get OTC approval from MHRA in UK

TSI Group Ltd is first to get OTC approval from MHRA in UK

Jan 5, 2021 | Science and Research

Nutritioninsight.com recently published the news that TSI Group Ltd gained approval from the UK Medicines and Healthcare Products Regulatory Agency (MHRA) to market the glucosamine we manufacture as a full strength, OTC formulation. Sold in the UK under the brand name Arthriex®, our glucosamine offers the only approved full dose, pharmaceutical grade formulation in the UK. The process of gaining this approval included developing an extensive drug dossier and demonstrating the safety, quality and dosage efficacy, and was made possible by bringing the full resources of TSI Group into the process. The net result is potential relief for millions in the UK who suffer from osteoarthritis.

Try tracing the individual ingredients in your favorite supplement brand to its source. There are no guarantees that the ingredients used by a particular brand come from the same manufacturer, even from one bottle to another. However when you see the Arthriex®, Pureflex® or GlucosaGreen® brands on the label you are assured that these ingredients are exclusively produced, distributed, and supported by TSI Group Ltd.

Read the full article here.